Cargando…
Risk factors for hospitalization, intensive care, and mortality among patients with asthma and COVID-19
Autores principales: | Wang, Liqin, Foer, Dinah, Bates, David W., Boyce, Joshua A., Zhou, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387277/ https://www.ncbi.nlm.nih.gov/pubmed/32735807 http://dx.doi.org/10.1016/j.jaci.2020.07.018 |
Ejemplares similares
-
Post–Acute COVID-19 Respiratory Symptoms in Patients With Asthma: An Electronic Health Records–Based Study
por: Wang, Liqin, et al.
Publicado: (2023) -
Comment on Albogami et al. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344–1352
por: Foer, Dinah, et al.
Publicado: (2021) -
Improving Mobile Health for Asthma in a Pandemic: Patient Use of an Integrated COVID-19 Screener
por: Foer, Dinah, et al.
Publicado: (2022) -
Systems Approaches to Treatment Response to Imatinib in Severe Asthma: A Pilot Study
por: Baek, Seung Han, et al.
Publicado: (2021) -
Utility of Hypoglycemic Agents to Treat Asthma with Comorbid Obesity
por: Ge, Derek, et al.
Publicado: (2022)